Estudo Clínico: Implantes de Joelhos Específicos para o Paciente com a Tecnologia Conformis são mais econômicos do que as dos implantes de ponta
March 18, 2021 12:40 ET
|
Conformis, Inc.
BILLERICA, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- A Conformis, Inc. (NASDAQ:CFMS) anunciou hoje que uma análise retrospectiva independente dos dados hospitalares concluiu que a tecnologia dos...
Estudio Clínico: Implante de reemplazo total de rodilla específico para paciente con tecnología Conformis es más económico que implantes tradicionales líderes
March 18, 2021 12:40 ET
|
Conformis, Inc.
BILLERICA, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) anunció hoy que un estudio retrospectivo independiente de datos hospitalarios concluyó que la tecnología de...
Clinical Study: Patient-Specific Total Knee Replacement with Conformis Technology Is More Cost-Effective Than with Leading Off-the-Shelf Implants
March 17, 2021 11:56 ET
|
Conformis, Inc.
BILLERICA, Mass., March 17, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that an independent, retrospective review of hospital data has concluded that Conformis iTotal®...
Clinical Study: Patient-Specific Total Knee Replacement with Conformis Technology Is More Cost-Effective Than with Leading Off-the-Shelf Implants
March 16, 2021 07:00 ET
|
Conformis, Inc.
BILLERICA, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that an independent, retrospective review of hospital data has concluded that Conformis iTotal®...
Conformis, Inc. Reports Fourth Quarter and Year End 2020 Financial Results
March 03, 2021 16:05 ET
|
Conformis, Inc.
BILLERICA, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the fourth quarter and year ended December 31, 2020. Fourth Quarter 2020...
Conformis, Inc. Announces Clearance in Australia for iTotal® PS, the Only Personalized, Posterior-Stabilized Total Knee Replacement System
March 01, 2021 17:45 ET
|
Conformis, Inc.
BILLERICA, Mass., March 01, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) today announced the clearance of its patient-specific iTotal® PS total knee replacement system by the Therapeutic...
Conformis, Inc. to Participate in Upcoming Investor Conferences
February 25, 2021 08:00 ET
|
Conformis, Inc.
BILLERICA, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. Announces Pricing of $85 Million Underwritten Offering of Common Stock
February 12, 2021 08:30 ET
|
Conformis, Inc.
BILLERICA, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has priced an underwritten public offering of 80,952,381 shares of its common stock at an...
Conformis, Inc. Announces Proposed Public Offering of Common Stock
February 11, 2021 16:01 ET
|
Conformis, Inc.
BILLERICA, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced that it intends to offer shares of its common stock in an underwritten public offering. Conformis...
Conformis, Inc. and SITES Medical Announce Development & Supply Agreement
January 21, 2021 16:15 ET
|
Conformis, Inc.
BILLERICA, Mass. and COLUMBIA CITY, Ind., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) and SITES Medical, a firm dedicated to inventing and de-risking new orthopedic medical...